PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical Lymphoma Myeloma and Leukemia10.1016/s2152-2650(20)30694-7202020S170ALL-315: Outcome of Adults with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaBachar Samra, Ahmad S. Alotaibi, Nicholas Short, Joseph Khoury, Farhad Ravandi, Rebecca Garris, Nitin Jain, Marina Konopleva, Hagop Kantarjian, Elie Jabbourhttps://api.elsevier.com/content/article/PII:S2152265020306947?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265020306947?httpAccept=text/plain
Cancer Research and Treatment10.4143/crt.2013.0472014464358-365Clinical Outcome of Relapsed or Refractory Burkitt Lymphoma and Mature B-Cell Lymphoblastic Leukemia in Children and AdolescentsHyery Kim, Eun Sil Park, Soo Hyun Lee, Hong Hoe Koo, Hyo Sun Kim, Chuhl Joo Lyu, So Eun Jun, Young Tak Lim, Hee Jo Baek, Hoon Kook, Ji Won Lee, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, Hyeo Seop Ahnhttp://www.e-crt.org/upload/pdf/crt-2013-047.pdf, http://www.e-crt.org/upload/pdf/crt-2013-047.pdf
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2016.02.001201616S2-S5Blinatumomab: Bridging the Gap in Adult Relapsed/Refractory B-Cell Acute Lymphoblastic LeukemiaStephanie A. Folan, Amber Rexwinkle, Jane Autry, Jeffrey C. Bryanhttps://api.elsevier.com/content/article/PII:S2152265016000562?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265016000562?httpAccept=text/plain
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2017.07.043201717S269-S270Use of Bortezomib in Pediatric Relapsed/Refractory Acute Lymphoblastic LeukemiaAdriana Bello, Rossana Cortez, Maylu Collazohttps://api.elsevier.com/content/article/PII:S2152265017310492?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265017310492?httpAccept=text/plain
Clinical Lymphoma Myeloma and Leukemia10.1016/s2152-2650(21)01646-3202121S265ALL-056: Outcome of Relapsed or Refractory Acute B-Lymphoblastic Leukemia Patients with Extramedullary Disease Receiving Inotuzumab OzogamicinSabine Kayser, Chiara Sartor, Nydia Panitz, Matthias Fante, Christoph Lutz, Daniel Wolff, Anthony Ho, Cristina Papayannidishttps://api.elsevier.com/content/article/PII:S2152265021016463?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265021016463?httpAccept=text/plain
British Journal of Haematology10.1111/j.1365-2141.2004.04925.x20041253414-415Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphomaMaaike J. De Vries, Anjo J. P. Veerman, Christian M. Zwaanhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.2004.04925.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.2004.04925.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2004.04925.x/fullpdf
Clinical Lymphoma Myeloma and Leukemia10.1016/s2152-2650(21)01288-x202121S206Poster: ALL-056: Outcome of Relapsed or Refractory Acute B-Lymphoblastic Leukemia Patients with Extramedullary Disease Receiving Inotuzumab OzogamicinSabine Kayser, Chiara Sartor, Nydia Panitz, Matthias Fante, Christoph Lutz, Daniel Wolff, Anthony Ho, Cristina Papayannidishttps://api.elsevier.com/content/article/PII:S215226502101288X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S215226502101288X?httpAccept=text/plain
Clinical Lymphoma Myeloma and Leukemia10.1016/s2152-2650(21)01261-1202121S187-S188Novel Treatment Approaches in Relapsed/Refractory Mantle Cell LymphomaKami Maddockshttps://api.elsevier.com/content/article/PII:S2152265021012611?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265021012611?httpAccept=text/plain
Pediatric Blood & Cancer10.1002/pbc.2599020166371214-1221Relapsed or Refractory Lymphoblastic Lymphoma in Children: Results and Analysis of 23 Patients in the EORTC 58951 and the LMT96 ProtocolsKatell Michaux, Christophe Bergeron, Virginie Gandemer, Fran├žoise Mechinaud, Anne Uyttebroeck, Yves Bertrand, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.25990, https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.25990
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2017.07.015201717S253-S254Nelarabine in Adult Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma(T-ALL/T-LBL): The Mayo Clinic ExperienceTheodora Anagnostou, Mark R. Litzow, Michelle A. Elliott, Aref Al-Kali, Naseema Gangat, Kristen B. McCullough, Hassan Alkhateeb, Mrinal M. Patnaikhttps://api.elsevier.com/content/article/PII:S2152265017310212?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265017310212?httpAccept=text/plain